RHEA Generics and Bayer Philippines Unite for World-class Quality, Affordable Stroke-Prevention Medication
In a milestone move that promises to transform healthcare accessibility in the Philippines, PHILUSA Corporation forged a partnership with Bayer Philippines to bring forth a new era of world-class quality medicines at affordable prices through RHEA Generics.
The ceremonial signing event was held at the Bayer Philippines Head Office on February 5, 2024, led by Mr. Neogin Evangelista, President and General Manager of PHILUSA Corporation; Mr. Angel Michaelo Evangelista, Managing Director and Country Division Head of Bayer Philippines; and Ms. Corazon Lim, Vice President for Merchandising of Mercury Drug Corporation.
This partnership marks the 12th collaboration for RHEA Generics, with Bayer Philippines joining the roster of RHEA Generics’ global pharmaceutical partners. Together, these industry giants aim to provide Filipino patients an effective medication for the prevention of stroke and treatment of thromboembolic events. “We’re here to help Filipino patients in accessing affordable generic medicines while ensuring their quality, safety, and efficacy,” said Mr. Neogin Evangelista.
The Philippines, with its diverse demographic and varying lifestyle patterns, is witnessing an increase in cases of stroke. According to the Department of Health (DOH), stroke is included in the top three leading causes of death in the country, affecting both urban and rural populations. Mr. Angel Michaelo Evangelista shared that there are more than half a million patients affected by this disease, and the partnership aims to redefine the standards of healthcare affordability and availability. “Our mission is health for all. We are committed to ensuring that a stroke-prevention medicine is made available through our partner, RHEA Generics. This will provide improved patient access to high-quality and affordable medicine.” The wide distribution reach of Mercury Drug is also instrumental in making public health within reach. Ms. Corazon Lim stated, “Our customers are assured of availability, affordability, and accessibility.”
Launched in 2014, RHEA Generics is a uni-brand of innovative generic medicines developed in partnership with global pharmaceutical leaders. Its portfolio of medicines includes treatments for hypertension, diabetes, hypercholesterolemia, respiratory infections, chronic kidney disease, among others.
Kapag may reseta ang doktor, Piliin ang RHEA Generics!
RHEA Generics is available at Mercury Drug branches nationwide.
